Treatment of anemia in pregnancy with intravenous iron therapy as compared to oral iron therapy.

Intravenous Iron Sucrose V/S Oral ferrous fumarate for treatment of anaemia in pregnancy.A randomisid controlled trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2016/12/007552

Enrollment

112

Registered

2016-12-08

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- anemic patients with hemoglobin level between 7 to 11 g/l

Interventions

Intervention1: Intravenous group -intravenous iron sucrose: intravenous iron sucrose 200 mg in 100ml normal saline intraveniusly over 20 to 30 minutes daily upto the total dose . Control Intervention1

Eligibility

Inclusion criteria

Inclusion criteria: hemoglobin level between 7 t0 11 gm/dl,serum ferritin less than 15 ng/ml,singleton pregnancy.

Exclusion criteria

Exclusion criteria: patients with history of bleeding tendancy,history of blood transfusion within prior 120 days,hemogolobinopathy or other red cell disorders,allergic asthma.

Design outcomes

Primary

Measure	Time frame
Intravenous iron sucrose is safe and effective in treatment of iron deficiency anemia in pregnanyTimepoint: Intravenous iron sucrose is safe and effective in treatment of iron deficiency anemia in pregnany.	—

Secondary

Measure	Time frame
Intravenous iron sucrose is indicated in rapid correction of anemia in pregnancy and restoring maternal iron stores.Timepoint: Intravenous iron sucrose improves maternal iron stores.	—

Countries

India

Contacts

Public ContactDr Shruti Bhavi

Shri.B.M.Patil Medical college

p.b.jaju@gmail.com9845241315

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 26, 2026